{"id":"W4417482017","doi":"10.1016/j.jval.2025.09.1068","title":"EE687 The Budget Impact and Time Savings of Introducing Subcutaneously Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenously Administered Nivolumab (NIVO IV) Across Indications in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Drug; Pharmacokinetics; Adverse effect; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530186,0.0003267079,0.0005306479,0.001448253,0.001145637,0.002650372,0.0008124161,0.0007205997,0.003068935],"category_scores_gemma":[0.01219499,0.0003419489,0.001499535,0.00339027,0.0007886776,0.0004891085,0.0009647756,0.00174751,0.0001187458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1282492,"about_ca_system_score_gemma":0.1469531,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.995483,"about_ca_topic_score_gemma":0.9965975,"domain_scores_codex":[0.9972114,0.0005240573,0.0001660346,0.0001592881,0.0007488719,0.001190323],"domain_scores_gemma":[0.9922249,0.001231168,0.001030123,0.00009465338,0.002528749,0.002890407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.008062516,0.000642999,0.7478055,0.001134237,0.003218761,0.0006246915,0.0007771071,0.03171713,0.0004949789,0.01046528,0.07241666,0.1226402],"study_design_scores_gemma":[0.00126105,0.0004730615,0.94669,0.0008864564,0.001660061,0.0002392508,0.002564424,0.01961957,0.0004717082,0.001333078,0.02466978,0.0001315184],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9197675,0.01275751,0.0004533548,0.02397685,0.0003239751,0.0002536364,0.02476092,0.00004660807,0.01765963],"genre_scores_gemma":[0.9867526,0.003758557,0.0004902086,0.001286133,0.00005092967,0.00004914431,0.004106692,0.00001668298,0.003489024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1282492,"threshold_uncertainty_score":0.9305173,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07352480237645068,"score_gpt":0.3594821933912759,"score_spread":0.2859573910148252,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}